Bringing Clinical Trials to Life

Oncology

Like our clients, we are committed to the quest to cure cancer. But cancer is not just a single disease. It takes deep trial knowledge to know how to address its many forms. Learn how Synteract has stayed ahead of the trends…More...

Neuro Degenerative

Neuro degenerative disorders are some of the most confounding and complex to affect people. Our specialized experience in these trials aids you in developing treatments that improve functioning and help the lives of both patients and caregivers…More...

Rare & Orphan Disease

Rare and orphan diseases have unique characteristics, not the least of which is finding the right population for your trials. We know the investigators and study sites that can help to address your recruitment goals, among other challenges…More...

Pediatrics

Pediatric trials run the gamut of indications in drug development, but they all have primary things in common – working with children and their families requires specialized expertise and deep knowledge of regulatory requirements….More...

6/24/2018 - 6/28/2018 : 2018 DIA Annual Meeting Booth # 1104 More...

4/19/2018: Synteract, an innovative contract research organization (CRO) providing full-service, Phase I-IV services to biopharma companies bringing new medicines to market, has enhanced its focus. More ...

5/31/2018: DIA 2018 Is On The Horizon! - Are you planning to attend DIA 2018 this year? We would love to see you there! Synteract will be exhibiting in Boston in booth #1104, June 24-28th.

Synteract Blog 

6/14/2018: This week our VP of Pediatric Development Dr. Martine Dehlinger-Kremer was featured in a Labiotech.eu article entitled ‘Riding the Wave of Pediatric Development." Click here https://lnkd.in/gbphJ2S to learn more about the collaboration between the EU and the US for  pediatric drug development. #pediatrics #drugdevelopment 

Synteract on LinkedIn

6/15/2018: We are with you from start to finish! Our CRAs have years of experience and provide a strong connecting link across… https://t.co/lEk3SJBmDK

Synteract Twitter Feed
x

Contact Synteract

Tell us how to stay in touch with you:

*Required